SCYX
SCYNEXIS INC
Nasdaq Pharmaceutical Preparations Non-accelerated filer
Smaller reporting company

Key Financials

Gross Profit
$3.6M
↑ 548.2%
Operating Income
$-16074000
↑ 56.7%
Net Income
$-8609000
↑ 59.6%
Total Liabilities
$9.7M
↓ 72.9%
Revenue
$20.6M
↑ 449.9%
Shareholders' Equity
$49.4M
↓ 10.4%
Total Assets
$59.0M
↓ 34.9%
Cash & Equivalents
$21.3M
↑ 32.4%

Recent SEC Filings

Form Type Filed Date Link
PRE 14A 4/17/2026 View on SEC
SCHEDULE 13G 4/8/2026 View on SEC
SCHEDULE 13G 4/7/2026 View on SEC
4 4/2/2026 View on SEC
8-K 3/31/2026 View on SEC
8-K 3/31/2026 View on SEC
8-K 3/31/2026 View on SEC
10-K 3/4/2026 View on SEC
SCHEDULE 13G/A 2/17/2026 View on SEC
SCHEDULE 13G/A 2/17/2026 View on SEC

Company Information

Field Value
Ticker SCYX
Company Name SCYNEXIS INC
CIK 1178253
Sector Pharmaceutical Preparations
Industry Non-accelerated filer
Smaller reporting company
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
Phone 201-884-5485